Drug Eluting Balloons (DEBs): Global Strategic Business Report

Quick Summary:

Ignite your strategic decision-making with the cutting-edge insights revealed in our latest market research report on the advancing Drug Eluting Balloons (DEBs) industry. With an estimated growth to a sizeable US$3 Billion by 2030, the wealth of opportunities within this high-growth market is too significant to overlook. The report delineates key factors driving this rapid expansion, explores various market segments, including the promising Peripheral segment predicted to reach an impressive US$1.7 Billion, and provides comprehensive insight into the trajectory of the Coronary segment.

The report doesn’t stop at global assessments. It transcends to regional analysis, pinpointing the growth potential in different markets including the U.S, China, Japan, Canada, and Germany. Understand the dynamics and growth opportunities of the DEBs market across these diverse geographies. Furthermore, dive into the competitive landscape with a detailed profiling of 42 industry contenders such as Acrostak Int. Distr. Sarl, B. Braun Melsungen AG, Cook Medical, Inc. and Medtronic PLC, among others. This report is instrumental in providing a holistic view of the DEBs industry and will empower your business to make calculated, data-driven decisions.

Global Drug Eluting Balloons (DEBs) Market to Reach $3 Billion by 2030

The global market for Drug Eluting Balloons (DEBs) estimated at US$1.3 Billion in the year 2022, is projected to reach a revised size of US$3 Billion by 2030, growing at a CAGR of 11.4% over the analysis period 2022-2030. Peripheral, one of the segments analyzed in the report, is projected to record 9.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Coronary segment is readjusted to a revised 14.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $385 Million, While China is Forecast to Grow at 11% CAGR

The Drug Eluting Balloons (DEBs) market in the U.S. is estimated at US$385 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$534.7 Million by the year 2030 trailing a CAGR of 11% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.6% and 9.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Select Competitors (Total 42 Featured) -

Acrostak Int. Distr. Sarl
B. Braun Melsungen AG
BARD, A Becton, Dickinson Company
Cardionovum GmbH
Cook Medical, Inc.
Eurocor GmbH
Medtronic PLC
Spectranetics Corporation

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

Frequently Asked Questions about the Global Market for Drug Eluting Balloons (DEBs)

What is the estimated value of the Global Market for Drug Eluting Balloons (DEBs)?

The Global Market for Drug Eluting Balloons (DEBs) was estimated to be valued at $1.3 Billion in 2022.

What is the growth rate of the Global Market for Drug Eluting Balloons (DEBs)?

The growth rate of the Global Market for Drug Eluting Balloons (DEBs) is 11.0%, with an estimated value of $3 Billion by 2030.

What is the forecasted size of the Global Market for Drug Eluting Balloons (DEBs)?

The Global Market for Drug Eluting Balloons (DEBs) is estimated to be worth $3 Billion by 2030.

Who are the key companies in the Global Market for Drug Eluting Balloons (DEBs)?

Key companies in the Global Market for Drug Eluting Balloons (DEBs) include Acrostak Int. Distr. Sarl, B. Braun Melsungen AG, BARD, A Becton, Dickinson Company, Cardionovum GmbH, Cook Medical, Inc., Eurocor GmbH, Medtronic PLC and Spectranetics Corporation.

Report Attribute	Details
No. of Pages	194
Published	September 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 1.3 Billion
Forecasted Market Value ( USD ) by 2030	$ 3 Billion
Compound Annual Growth Rate	11.0%
Regions Covered	Global

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
Drug Eluting Balloons (DEBs) - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Drug Eluting Balloons (DEBs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Drug Eluting Balloons (DEBs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 6: World 16-Year Perspective for Cath Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 9: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 12: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 13: World Drug Eluting Balloons (DEBs) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
Table 14: World Recent Past, Current & Future Analysis for Peripheral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 15: World Historic Review for Peripheral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 16: World 16-Year Perspective for Peripheral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 17: World Recent Past, Current & Future Analysis for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 18: World Historic Review for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 19: World 16-Year Perspective for Coronary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES

Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
Table 20: USA Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 21: USA Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 22: USA 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 23: USA Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 24: USA Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 25: USA 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

CANADA

Table 26: Canada Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 27: Canada Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 28: Canada 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 29: Canada Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 30: Canada Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 31: Canada 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

JAPAN

Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 32: Japan Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 33: Japan Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 34: Japan 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 35: Japan Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 36: Japan Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 37: Japan 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

CHINA

Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 38: China Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 39: China Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 40: China 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 41: China Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 42: China Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 43: China 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

EUROPE

Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 44: Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 45: Europe Historic Review for Drug Eluting Balloons (DEBs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 46: Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
Table 47: Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 48: Europe Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 49: Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 50: Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 51: Europe Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 52: Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

FRANCE

Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 53: France Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 54: France Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 55: France 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 56: France Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 57: France Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 58: France 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

GERMANY

Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 59: Germany Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 60: Germany Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 61: Germany 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 62: Germany Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 63: Germany Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 64: Germany 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

ITALY

Table 65: Italy Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 66: Italy Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 67: Italy 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 68: Italy Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 69: Italy Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 70: Italy 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

UNITED KINGDOM

Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 71: UK Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 72: UK Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 73: UK 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 74: UK Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 75: UK Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 76: UK 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

REST OF EUROPE

Table 77: Rest of Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 78: Rest of Europe Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 79: Rest of Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 80: Rest of Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 81: Rest of Europe Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 82: Rest of Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

ASIA-PACIFIC

Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 84: Asia-Pacific Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 85: Asia-Pacific 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 87: Asia-Pacific Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 88: Asia-Pacific 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

REST OF WORLD

Table 89: Rest of World Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 90: Rest of World Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 91: Rest of World 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2023 & 2030
Table 92: Rest of World Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 93: Rest of World Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 94: Rest of World 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030

IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

Acrostak Int. Distr. Sarl
B. Braun Melsungen AG
BARD, A Becton, Dickinson Company
Cardionovum GmbH
Cook Medical, Inc.
Eurocor GmbH
Medtronic PLC
Spectranetics Corporation

Quick Summary:

Global Drug Eluting Balloons (DEBs) Market to Reach $3 Billion by 2030

The U.S. Market is Estimated at $385 Million, While China is Forecast to Grow at 11% CAGR

Select Competitors (Total 42 Featured) -

What's New?

What is the estimated value of the Global Market for Drug Eluting Balloons (DEBs)?

What is the growth rate of the Global Market for Drug Eluting Balloons (DEBs)?

What is the forecasted size of the Global Market for Drug Eluting Balloons (DEBs)?

Who are the key companies in the Global Market for Drug Eluting Balloons (DEBs)?

Table of Contents

Companies Mentioned

Related Topics

Related Reports

The Global Market for Medical Devices, 12th Edition

Drug Delivery Market Forecast to 2028 - Global Analysis By Route of Administration, Distribution Channel, and End User

Global Drug Eluting Balloon Market by Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon), Coating Technology (EnduraCoat, FreePac, Paccocath), End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030

Drug Eluting Balloon Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

Global Drug-eluting Balloon Catheters Market Analysis & Forecast to 2023-2033: Market By Drug; By Indication; By End User; and By Region